Lombard Odier Asset Management (Switzerland)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-155,411
| Closed | -$15.1M | – | 177 |
|
|
2023
Q1 | $15.1M | Sell |
155,411
-50,802
| -25% | -$4.94M | 1.32% | 21 |
|
|
2022
Q4 | $21.3M | Sell |
206,213
-16,725
| -8% | -$1.73M | 1.71% | 10 |
|
|
2022
Q3 | $18.9M | Sell |
222,938
-27,579
| -11% | -$2.34M | 1.6% | 16 |
|
|
2022
Q2 | $20.8M | Sell |
250,517
-41,353
| -14% | -$3.43M | 1.76% | 15 |
|
|
2022
Q1 | $22.5M | Buy |
+291,870
| New | +$22.5M | 1.77% | 21 |
|
|
2016
Q2 | – | Sell |
-674
| Closed | -$56K | – | 308 |
|
|
2016
Q1 | $56K | Hold |
674
| – | – | 0.01% | 392 |
|
|
2015
Q4 | $71K | Buy |
+674
| New | +$71K | 0.01% | 403 |
|
|
2014
Q4 | – | Sell |
-108,400
| Closed | -$7.83M | – | 436 |
|
|
2014
Q3 | $7.83M | Buy |
+108,400
| New | +$7.83M | 0.2% | 130 |
|